Human autologous dendritic cell-glioma fusions: Feasibility and capacity to stimulate T cells with proliferative and cytolytic activity

Journal of Neuro-Oncology

Volumn 64, Issue 1, 2003, Pages 177-183

  Sloan, Andrew E ^a   Parajuli, Prahlad ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Apoptotic cells; Dendritic cells; Fushion; Hybrids; Immunotherapy; Lymphocytes

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIBODY CLASS 1; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY RESPONSE; APOPTOSIS; BLOOD; CELL FUSION; CELL PROLIFERATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; DRUG EFFECT; FEASIBILITY STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PHENOTYPE; STAINING; T LYMPHOCYTE; TUMOR CELL;

EID: 0042062585     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024999707415     Document Type: Conference Paper

References (31)

1. Steinman RM, Dhodapkar M: Active immunization against cancer with dendritic cells: The near future. Int J Cancer 94: 459-473, 2001
2. Brossart P, Wirths S, Brugger W, Kanz L: Dendritic cells in cancer vaccines. Exp Hematol 29: 1247-1255, 2001
3. Sprinzl GM, Kacani L, Schrott-Fischer et al.: Dendritic cell vaccines for cancer therapy. Cancer Treat Rev 27: 247-255, 2001
4. Parajuli P, Sloan AE: Dendritic cell-based immunotherpy of malignant gliomas. Cancer Invest 2002 (in press)
5. Soling A, Rainov NG: Dendritic cell therapy of primary brain tumors. Mol Med 7: 659, 2001
6. Heimberger AB, Crotty LE, Archer GE et al.: Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 103: 16-25, 2000
7. Aoki H, Mizuo M, Natsume A et al.: Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor. Cancer Immunol Immunother 50: 463-468, 2001
8. Ni H, Speilma SR, Jean WC et al.: Immunization with dendritic cells pulsed with tumor extract increase survival of mice bearing intracerebral gliomas. J Neuro-Oncol 51: 1-9, 2000
9. Liau LM, Black KL, Martin NA et al.: Treatment of a glioblastoma patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case report. Neurosurg Focus 9: 1-5, 2000
10. Ashley, DM, Faiola B, Nair S: Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce anti-tumor immunity against central nervous system tumors. J Exp Med 186: 1177-1182, 1997
11. Witham TF, Erff ML, Okada H et al.: 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model. Neurosurgery 50: 1327, 2002
12. Yu JS, Wheeler CJ, Zelter PM et al.: Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T cell infiltration. Cancer Res 61: 842-847, 2001
13. Yu JS, Wheeler CJ, Zeltzer PM et al.: Dendritic cell immunotherapy for patients with glioblastoma multiforme and anaplastic astrocytoma. Proc Am Assoc Cancer Res 42: 1478, 2001 (abstract)
14. Wang J, Saffold S, Cao X, Krauss J, Chen W: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 161: 5516, 1998
15. Cao X, Zhang W, Wang J, Zhang M, Huang X, Hamada H, Chen W: Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells. Immunology 97: 616, 1999
16. Gong J, Nikrui N, Chen D, Koido S, Wu Z, Tanaka Y, Cannistra S, Avigan D, Kufe D: Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity. J Immunol 165: 1705, 2000
17. Gong J, Avigan D, Chen D, Wu Z, Koido S, Kashiwaba M, Kufe D: Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 97: 2715, 2000
18. Kugler A, Stuhler G, Walden P et al.: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med 6: 332-336, 2000
19. Akasaki Y, Kikuchi T, Homma S et al.: Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 24: 106-113, 2001
20. Kikuchi T, Akasaki Y, Irie M et al.: Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother 50: 337-344, 2001
21. Yang T, Witham TF, Villa L et al.: Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: Implications for the use of dendritic cells for therapy of gliomas. Cancer Res 62: 2583, 2002
22. Jenne L, Arright J, Jonuleit H et al.: Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Cancer Res 60: 4446-4452, 2000
23. Kotera Y, Shimizu K, Mule JJ: Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res 61: 8105-8109, 2001
24. Sloan AE, Dansey R, Zamarano L et al.: Adoptive immunotherapy in patients with recurrent malignant glioma: Preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes. Neurosurg Focus 9(6): 9, 1-8, 2000
25. Albert ML, Sauter B, Bhardwaj: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89, 1998
26. Dix AR, Brooks WH, Roszman TL, Morford LA: Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 100: 216, 1999
27. Albert ML, Jegathesan M, Darnell RB: Dendritic cell maturation is required for the cross-tolerization of CD8+T cells. Nat Immunol 2(11): 1010-1017, 2001
28. Schoenberger SP, Toes RE, Van Der Voort EI, Offringa R, Melief CJ: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483, 1998
29. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393: 478-480, 1998
30. Sloan AE, Parajuli P, Mathupala SP: DC-tumor cell fusion for induction of tumor-specific T-cell response against malignant brain tumors: Comparison with DC pulsed with total tumor RNA or tumor lysate. Proc Amer Assoc Cancer Res Abstract 476, 2002
31. Parajuli P, Mathupala S, Sloan: DC-tumor cell fusion or DC loaded with apoptotic glioma cells stimulate both T and NK-like T cells with tumor-cytolytic activity. Congress of Neurologic Surgery, Chicago Il, April 22 (Published abstract)